Understanding Amino Acid Sequences in Peptides

For laboratory research use only; not for human consumption.

Why sequence is identity

Change a single amino acid in a fifteen-residue chain and you can end up with a molecule that behaves nothing like the original. A peptide's identity is therefore not its name but its sequence. Two products marketed under similar names can be structurally unrelated if even one residue differs, and it is the sequence, not the label, that determines how a compound behaves in a research model. This guide explains how chains are built, how to read the notation, how sequence determines mass, and what that means when you read a certificate of analysis.

How a peptide chain is built

Amino acids link through peptide bonds, a condensation reaction between the carboxyl group of one amino acid and the amino group of the next that releases one water molecule at each junction. A chain of n residues therefore has n − 1 bonds. By convention a sequence is always written from the free amino group (the N-terminus) to the free carboxyl group (the C-terminus), so the order of the listed residues matches the actual chemical order of the chain.

Chain length is the first way peptides are classified. There is no sharp boundary, but a rough working scale is useful:

Reading sequence notation

Sequences are written with three-letter codes (Gly for glycine, Pro for proline) or compactly with single-letter codes. The twenty standard residues and their codes are below.

BPC-157, for example, is written Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, or GEPPPGKPADDAGLV in single letters: fifteen residues in the exact order they occur from N- to C-terminus. Its profile is described in the BPC-157 research overview, and the BPC-157 research vial is listed on the shop.

Features outside the standard twenty

Many research peptides contain modifications that are part of the full identity and must be reflected in documentation:

• D-amino acids. Melanotan II contains D-phenylalanine, which resists enzymatic cleavage. A D-to-L swap leaves the mass unchanged, so mass spectrometry alone cannot detect it.
• Cyclization. Disulfide bridges (cysteine to cysteine, about −2 Da relative to the reduced chain) or lactam bridges (side-chain amide, −18 Da relative to the linear precursor) lock a conformation. Melanotan II is cyclized by a lactam between aspartic acid and lysine.
• Terminal caps. N-terminal acetylation (about +42 Da) and C-terminal amidation (about −1 Da relative to the free acid) change charge and stability. Melanotan II carries both.
• Non-natural residues. Norleucine (Nle) in Melanotan II, and aminoisobutyric acid (Aib) in semaglutide, are engineered for stability.
• Lipidation. A fatty-acid chain attached to a lysine side chain, as in semaglutide and cagrilintide, prolongs persistence in solution.

Melanotan II's full notation, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, encodes all of these at once; see Melanotan II research overview.

How sequence determines mass

A peptide's molecular formula and weight are direct consequences of its sequence, because every residue contributes a known, fixed mass. The average mass is the sum of the residue masses plus one water (about 18.02 Da) for the free termini. Worked examples, using average residue masses:

This is what makes mass spectrometry an identity check: measure the intact mass, compare it with the value predicted from the stated sequence, and the lab can confirm or rule out that the material matches its labeling. If the prediction is off by 128 Da, a lysine is missing; if off by 57 Da, a glycine; if off by 16 Da, an oxidation. The pattern of differences usually points to the fault. That check is independent of any purity measurement.

Purity and identity are different questions

HPLC reports how much of the sample elutes as one peak; it does not say which molecule that peak is. A legitimate certificate of analysis reports both, rather than treating a purity percentage as sufficient on its own. Background on the chromatography side is in understanding HPLC purity, and independent verification in third-party testing explained. Lot-specific certificates are on the CoA page.

Sequence differences that matter in practice

Within the research space, sequence-level differences explain why closely related compounds are studied as different tools. Tirzepatide's sequence gives it activity at both the GIP and GLP-1 receptors, while semaglutide's sequence restricts it to GLP-1 alone; the receptor biology is in incretin receptors explained. Likewise, the tripeptide KPV is the C-terminal end of alpha-MSH, while Melanotan II is a cyclic analog of the central region of the same hormone; see KPV vs. alpha-MSH. The sequence is the variable that defines the compound; purity, formulation and packaging describe how faithfully a given vial reproduces it.

Practical habits for reading a sequence

When a new compound enters a project, write out its full notation and check it against two independent sources before ordering: the supplier documentation and the primary literature. Note the length, count the residues, and identify every feature that is not a plain L-amino acid. Compute the expected average mass yourself, as in the table above, and compare it with the value on the certificate; a discrepancy found before an experiment costs a question, while one found afterward can cost the dataset. Keep in mind that quoted masses can be average or monoisotopic, and that the observed ion may carry extra protons, so confirm which convention is being reported. Isomeric swaps and sequence order errors between residues of identical composition are invisible to a mass check, which is why synthesis control and clear documentation remain part of the answer.

Why product names alone are not reliable

A compound name is a convenient label, not a chemical guarantee. Nothing about a listing title confirms that the material was verified against the sequence it implies. Identity testing closes that gap. Regard the sequence, not the name, as the specification, and prefer documentation that states the sequence explicitly. When a vial is in hand, concentration planning uses the labeled mass; the calculator converts it to mg/mL for a chosen diluent volume. See also what are research peptides.

Frequently asked questions

What is the N-terminus?

The end of the chain with a free amino group. Sequences are written from the N-terminus to the C-terminus, which has a free carboxyl group.

What is the difference between three-letter and one-letter codes?

They are two notations for the same residues, for example Gly or G for glycine. One-letter codes are more compact for long chains.

How does a sequence determine molecular weight?

Each residue has a fixed mass. Adding the residue masses and one water molecule gives the average molecular weight, for example about 340.4 Da for GHK.

Why can mass spectrometry confirm identity?

Because the measured mass of the intact molecule can be compared with the mass predicted from the stated sequence. A mismatch indicates a different or modified molecule.

Can mass alone detect every sequence error?

No. Swapping D- and L-forms of a residue, or two residues of equal mass, leaves the mass unchanged and needs other methods.

What are D-amino acids and why do they appear?

Mirror-image forms of the usual L-residues. They resist enzymatic cleavage, so they are used to stabilize peptides such as Melanotan II.

What does a mass 128 Da too low indicate?

That is the residue mass of lysine, suggesting a deletion of one lysine from the chain.

What should a certificate of analysis state?

The compound identity or sequence, HPLC purity, mass-spec result, batch number and test date. See the CoA page.

For laboratory research use only; not for human consumption.

Research Use Only. Supplied strictly for laboratory research and development. Not for human or veterinary use, consumption, or any diagnostic purpose. This article is research education, not usage guidance.

References

1. V8 Peptides. HPLC vs. mass spectrometry.
2. V8 Peptides. How to read a certificate of analysis.
3. V8 Peptides. Understanding HPLC purity.
4. V8 Peptides. BPC-157 research overview.
5. V8 Peptides. Melanotan II research overview.
6. V8 Peptides. Incretin receptors explained.